We are here to drive safer, more precise spine surgery by delivering next generation guidance, real-time surgical intelligence, and structured intraoperative data.
Mission
Power the evolution to data driven outcomes in healthcare.
Vision
To make great healthcare outcomes accessible to all.
%20(1).png)
.png)
Proprio was founded on the principle of proprioception, how the body senses its position in space. We bring that same real-time awareness to surgery through dynamic, data-driven visualization.
Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology.
%20(1).png)
Proprio was founded out of research in computer vision and human perception at the University of Washington, inspired by a core insight:
Surgery operates in a dynamic, three-dimensional world, but traditional guidance tools were built for static snapshots.
Drawing from the science of proprioception (the body’s ability to sense its position and movement), Proprio set out to give surgeons a new kind of spatial awareness in the operating room through optical sensing, AI, and real-time measurement.
The result: a new category of surgical intelligence designed for dynamic surgery, not still images.
Our executive team has extensive experience in technology, neurosurgery, computer vision, and orthopedics. With dozens of FDA-approved products successfully brought to market, our leaders come from small, mid, and large technology and medical device companies, both private and public.
%20(1).png)
Gabriel Jones is the CEO of Proprio, which he co-founded in 2016 with Seattle Children's Hospital neurosurgeon Dr. Samuel Browd, University of Washington Professor Joshua Smith, and computer vision specialist James Youngquist. The team set out to create a system that makes surgeons more precise and exponentially increases surgical accuracy and efficiency.
.svg)
Jones is a well-known and experienced technology leader with a passion for helping others and bringing innovation to life. Jones has more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI and healthcare. He began his career in international trade in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street. Prior to founding Proprio, Jones helped clients like Bill Gates and the leadership of Microsoft evaluate and develop emerging technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact, his work led him to technology ventures. He has assisted several successful startups on their commercialization path, from biotech and med tech, to AI and prop tech. Gabe has held seats on several boards including the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.
%20(1).png)
Shannon brings 25 years of medical device experience in both early stage companies and large corporations. In her 27 year career she has been responsible for new product development, product manufacturing, and quality systems and has led teams along the full spectrum of the development lifecycle in a wide variety of clinical applications.
Prior to joining Proprio she served as VP, Device Development for L'Oreal, VP of Engineering and Operations for an early stage start-up, Aortica Corporation and over a decade at Pathway Medical last acting as Director of Engineering. In her role at Pathway Medical she was a key part of the leadership team successfully transitioning the technology to Bayer Healthcare. Shannon holds a BS in Mechanical Engineering from Louisiana State University.
Jennifer brings 20 years of experience in early and growth stage companies as well as large corporations in finance, human resources, operations and legal/compliance.
Prior to joining Proprio, Jennifer has lead finance and operations teams in biotech, clean energy, SaaS and consulting with a focus on helping organizations scale and finance their growth. She has facilitated fundraising rounds led by VC, strategics and individual investors.
Prior to joining Proprio she was the CFO of Resolution Bioscience, a medical device company focused on cutting edge diagnostics to advance the treatment of cancer. She was instrumental in the successful acquisition of Resolution Bioscience by Agilent Technologies and served as a VP, Finance & Operations for Agilent in their companion diagnostics division. Jennifer has also served in several other finance and operations leadership positions including most recently as VP, Operations & Controller for Modern Hydrogen.
Jennifer holds a BS in Economics from Western Washington University and is an actively licensed CPA.
Sharif has 30+ years experience in Medical Device, Software Development and novel 3D Visualization. He is inventor of 28 patents and lead products and interdisciplinary teams from initial invention, pre-clinical and clinical evaluation, FDA clearance, manufacturing, licensing to daily use.
His technologies are sold by Hologic, Medtronic and others. Sharif worked for both start-ups and Fortune 500 companies, including at Medtronic, where he served as a Chief Engineer of Interventional Imaging and was awarded Innovator of the Year in 2018.
Jones is a well-known and experienced technology leader with a passion for helping others and bringing innovation to life. Jones has more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI and healthcare. He began his career in international trade in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street. Prior to founding Proprio, Jones helped clients like Bill Gates and the leadership of Microsoft evaluate and develop emerging technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact, his work led him to technology ventures. He has assisted several successful startups on their commercialization path, from biotech and med tech, to AI and prop tech. Gabe has held seats on several boards including the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.
Prior to joining Proprio she served as VP, Device Development for L'Oreal, VP of Engineering and Operations for an early stage start-up, Aortica Corporation and over a decade at Pathway Medical last acting as Director of Engineering. In her role at Pathway Medical she was a key part of the leadership team successfully transitioning the technology to Bayer Healthcare. Shannon holds a BS in Mechanical Engineering from Louisiana State University.
Prior to joining Proprio, Jennifer has lead finance and operations teams in biotech, clean energy, SaaS and consulting with a focus on helping organizations scale and finance their growth. She has facilitated fundraising rounds led by VC, strategics and individual investors.
Prior to joining Proprio she was the CFO of Resolution Bioscience, a medical device company focused on cutting edge diagnostics to advance the treatment of cancer. She was instrumental in the successful acquisition of Resolution Bioscience by Agilent Technologies and served as a VP, Finance & Operations for Agilent in their companion diagnostics division. Jennifer has also served in several other finance and operations leadership positions including most recently as VP, Operations & Controller for Modern Hydrogen.
Jennifer holds a BS in Economics from Western Washington University and is an actively licensed CPA.
His technologies are sold by Hologic, Medtronic and others. Sharif worked for both start-ups and Fortune 500 companies, including at Medtronic, where he served as a Chief Engineer of Interventional Imaging and was awarded Innovator of the Year in 2018.
.png)
The Proprio Team is growing and needs creative thinkers and innovative problem solvers ready to make an impact!
.svg)
.svg)
